Angelo Termine

Angelo Termine is the Chief Executive Officer and President of Ki Health Partners LLC doing business  as New England Institute for Neurology and Headache,  New England Institute for Clinical Research, our clinical research center, as well as Ki Clinical Research, a site  management organization (SMO) providing business, development and regulatory expertise to medical practices wishing to engage in clinical research.

Angelo started his career in research at Yale University, School of Medicine, Department of Psychiatry in New Haven.  He then transitioned to Research Manager at a large neurology practice in Fairfield, where he participated in more than 100 studies, and successfully lead a team of clinical research coordinators for more than eight years before the launch of Ki Health Partners, LLC. In addition to holding master’s degrees in science management and business administration, Angelo is certified as a Clinical Research Associate, Clinical Research Coordinator,  and Clinical Research Contract Professional. He is a certified rater with extensive experience on the following scales: NIH Stroke Scale, ADAS-Cog, NPI, MMSE and multiple clinical psychiatric assessment certifications. He is a member of MAGI (Models Agreements and Guidelines International) as well as the Headache Cooperative of New England, has lectured extensively on clinical research throughout the country,  and has coauthored numerous scientific papers.

Frank Keulen

Frank is a seasoned Director of Program Delivery with over 15 years of international experience within the CRO MedTech environment. Frank leads the EU MedTech Project Management team at Premier Research. As a strategy lead, Frank develops fit-for-purpose proposals, provides strategic oversight on several device programs, and acts as a first level point of contact for executive client contacts. He ensures effective management and coordination across global project teams to support milestone achievements and successful project delivery.

Frank’s background spans the entire device lifecycle, including First-in-Man (FIM), pre- and post-market, and registry studies, with global project coverage across several indications with a main focus on (interventional) cardiology and dermatology.

Before joining Premier Research, Frank held clinical project management roles at Medpace and MediTech Strategic Consultants. He holds an MSc in Physical Activity and Health, specializing in Human Performance and Health Biology from Maastricht University.

Markus Mueller

Markus Mueller is the co-founder of GauVendi, bringing 25+ years of leadership in tourism across Europe, the Middle East, the Caribbean, and Asia, working with Mövenpick, Hyatt, IHG, and Marriott. He holds an MBA with Distinction from Warwick Business School.

As a founder, he has pioneered a new way to manage, price, and sell real estate-based experiences, using AI-driven dynamic matching to connect properties with travelers—enabling personalized stays instead of generic room bookings. His innovations have led to 20% higher revenues, 70% automation of reservation processes, and a 30% increase in Net Promoter Scores.

Fred Moreau

Fred Moreau is the Director of Centralized Ancillary Supply Management at Takeda Pharmaceuticals.  His responsibilities include development & implementation of supply strategies to facilitate and support the delivery of ancillary supplies.

 

Fred has over 20 years of experience in the pharmaceutical and medical device industry.  In his career he has been responsible for clinical and commercial supply planning for multiple programs; product lifecycle management; strategic sourcing; and planning for new product launches.